Correlation between morphologic and other prognostic markers of neuroblastoma a study of histologic grade, DNA index, N‐myc gene copy number, and lactic dehydrogenase in patients in the pediatric oncology group

Background. Histologic grades (HG), N‐myc (NM) gene copy number, DNA index (DI), and serum lactic dehydrogenase (LDH) have been shown to be related to prognosis in neuroblastoma. The relationship between HG and nonmorphologic prognostic markers has not been investigated previously.

[1]  J. Shuster,et al.  Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study , 1992, American journal of clinical oncology.

[2]  K. Alitalo,et al.  Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation , 1992, Science.

[3]  J. Shuster,et al.  Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the pediatric oncology group , 1992, Cancer.

[4]  J. Shuster,et al.  Age‐linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the pediatric oncology group , 1992, Cancer.

[5]  M. Schwab,et al.  The N‐Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. , 1991, The EMBO journal.

[6]  A T Look,et al.  Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  T. Jahnsen,et al.  N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables. , 1989, Journal of clinical pathology.

[8]  J. Wasson,et al.  Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. , 1987, Cancer research.

[9]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[10]  H. Sather,et al.  Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. , 1985, Cancer research.

[11]  H. B. Marsden,et al.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.

[12]  A. Look,et al.  Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. , 1984, The New England journal of medicine.

[13]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[14]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[15]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[16]  K. Yanagi,et al.  Selective staining by 4', 6-diamidine-2-phenylindole of nanogram quantities of DNA in the presence of RNA on gels. , 1979, Nucleic acids research.

[17]  J. Kapuściński,et al.  Simple and rapid fluorimetric method for DNA microassay. , 1977, Analytical biochemistry.

[18]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[19]  N. Breslow,et al.  Statistical estimation of prognosis for children with neuroblastoma. , 1971, Cancer research.